About Aryastha Life Sciences Private Limited
Data last updated:
Aryastha Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 18 July 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U72100TS2023PTC175080.
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹1.6 Lakh. It is led by directors including Pradip Kumar Majumder and Raghava Reddy Kethiri.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹84,463. For the same year it recorded a net loss of ₹45.73 Lakh and EBITDA of -₹57.94 Lakh.
The company is associated with 1 brand: Aryastha. As per MCA filings, the company has open charges of ₹16.92 Cr on record.
For more details, the company can be reached via its website aryastha.com.
Company details
Contact details
Aryastha Life Sciences Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressVilla No. 72, Vessella Meadows, Hyderabad, Telangana, India – 500031
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Aryastha Life Sciences operates one associated brand: Aryastha. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Contract research services for drug discovery and development are provided. | aryastha.com |
Business activity
The main business activity of Aryastha Life Sciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
Financials of Aryastha Life Sciences Private Limited
FY 2025 filings availableAryastha Life Sciences Private Limited reported revenue of ₹84,463 for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹57.94 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹45.73 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2023-24 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Aryastha Life Sciences Private Limited, buy the company report.
Board of directors of Aryastha Life Sciences Private Limited
Aryastha Life Sciences has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajasekar Narayanasamy | Additional Director | 31 Dec 2023 | 2 Years 9 Months | Current |
| Pradip Kumar Majumder | Director | 18 Jul 2023 | 3 Years 3 Months | Current |
| Sivananda Reddy Mandra Also directs: Vessella Greens LLP, Vessella Valley LLP, Vessella Life Sciences Private Limited and 4 more | Additional Director | 31 Dec 2023 | 2 Years 9 Months | Current |
| Raghava Reddy Kethiri | Director | 18 Jul 2023 | 3 Years 3 Months | Current |
| Mark Timothy Bilodeau | Director | 06 Oct 2025 | 1 Years 0 Months | Current |
Peer comparison
Aryastha Life Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Noble Research Publishers Private Limited | ₹98,271 (FY 2025) | 63.0% | Hyderabad, Telangana, India | |||
| Novelgenix Therapeutics Private Limited | ₹93,183 (FY 2025) | -98.0% | Ahmedabad, Gujarat, India | |||
| Aryastha Life Sciences Private Limitedthis company | ₹84,463 (FY 2024) | -₹45.73 Lakh | Hyderabad, Telangana, India | |||
| Sphaera Pharma Research and Development Private Limited | ₹67,500 (FY 2025) | -83.0% | New Delhi, Delhi, India | |||
| Gomi'da Private Limited | ₹63,000 (FY 2024) | -96.0% | Noida, Uttar Pradesh, India |
To see the full peer comparison of Aryastha Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Jul 2024 | 100955462 | Hdfc Bank Limited | ₹38.35 Lakh | Open | |
| 04 May 2024 | 100915198 | Hdfc Bank Limited | ₹43.84 Lakh | Open | |
| 28 Mar 2024 | 100907978 | Hdfc Bank Limited | ₹16.1 Cr | Open |
To see the full charge records of Aryastha Life Sciences Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Aryastha Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aryastha Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aryastha Life Sciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aryastha Life Sciences Private Limited has 6 board changes on record since 2023: 5 appointments and 1 cessation. The latest: Mark Timothy Bilodeau was appointed as Director on 06 Oct 2025.
1 earlier event is in the company report.
Frequently asked questions
Aryastha Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 18 July 2023 (3+ years old) and is registered under CIN U72100TS2023PTC175080.
Aryastha Life Sciences has 5 current directors:
- Rajasekar Narayanasamy - Additional Director
- Pradip Kumar Majumder - Director
- Sivananda Reddy Mandra - Additional Director
- Raghava Reddy Kethiri - Director
- Mark Timothy Bilodeau - Director
The latest financial statements of Aryastha Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Aryastha Life Sciences is U72100TS2023PTC175080. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aryastha Life Sciences was incorporated on 18 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Aryastha Life Sciences by revenue are Noble Research Publishers Private Limited, Novelgenix Therapeutics Private Limited, Sphaera Pharma Research and Development Private Limited, Gomi'da Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Mark Timothy Bilodeau was appointed as Director on 06 Oct 2025. Ashish Kumar ceased to be Director on 27 Sep 2025. Rajasekar Narayanasamy was appointed as Additional Director on 31 Dec 2023. Aryastha Life Sciences has 6 board changes on record in total.
Aryastha Life Sciences can be reached through the website aryastha.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Aryastha Life Sciences is at Villa No. 72, Vessella Meadows, Hyderabad, Telangana, India – 500031.
Aryastha Life Sciences operates in the pharma industry, in the pharma contract r and d segment.
Aryastha Life Sciences has open charges of ₹16.92 Cr and no satisfied charges on record as per latest MCA filings.